Danielle Ulanet
Xilio Therapeutics (United States)(US)
Publications by Year
Research Areas
DNA Repair Mechanisms, Cancer Genomics and Diagnostics, Biochemical and Molecular Research, Adolescent and Pediatric Healthcare, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status(1999)486 cited
- → Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase(2013)331 cited
- → Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy(2010)234 cited
- → Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results(2023)95 cited
- → Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH(2016)68 cited
- → Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response(2003)65 cited
- → Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension(2003)63 cited
- → Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition(2014)42 cited
- → Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase(2020)34 cited
- → Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: Insights into the association of specific autoantibodies with distinct disease phenotypes(2004)34 cited